Sidney Lupkin

You know, that's unclear. Executive orders can only do so much. In this case, the action is telling the FDA to take certain steps, instructing his HHS secretary to work with Congress, instructing officials to come up with regulatory solutions. So a lot will depend on all these different players working together.

On, for example, drug importation, states have to submit very specific plans for each drug they want to import even after the FDA approves their general approach. FDA approved Florida's drug importation program last January, but by November, it still wasn't bringing in drugs from Canada.

On, for example, drug importation, states have to submit very specific plans for each drug they want to import even after the FDA approves their general approach. FDA approved Florida's drug importation program last January, but by November, it still wasn't bringing in drugs from Canada.

On, for example, drug importation, states have to submit very specific plans for each drug they want to import even after the FDA approves their general approach. FDA approved Florida's drug importation program last January, but by November, it still wasn't bringing in drugs from Canada.

So this presidential order could build on efforts to lower drug prices, but only if Congress and other officials find a way to solve some of these challenges.

So this presidential order could build on efforts to lower drug prices, but only if Congress and other officials find a way to solve some of these challenges.

So this presidential order could build on efforts to lower drug prices, but only if Congress and other officials find a way to solve some of these challenges.

You bet.

You bet.

You bet.

Novo Nordisk is joining its competitor Eli Lilly and offering its obesity drug direct-to-consumers at a discount. Lilly started offering vials of its weight loss drug Zepbound online last summer. The direct-to-consumer model is fairly new to the pharmaceutical industry, but it wouldn't work for every medicine, says Dr. Ben Rome, a health policy researcher at Brigham and Women's Hospital in Boston.

Novo Nordisk is joining its competitor Eli Lilly and offering its obesity drug direct-to-consumers at a discount. Lilly started offering vials of its weight loss drug Zepbound online last summer. The direct-to-consumer model is fairly new to the pharmaceutical industry, but it wouldn't work for every medicine, says Dr. Ben Rome, a health policy researcher at Brigham and Women's Hospital in Boston.

According to the Centers for Disease Control and Prevention, two in five American adults is obese. Sydney Lepkin, NPR News.

According to the Centers for Disease Control and Prevention, two in five American adults is obese. Sydney Lepkin, NPR News.